What is APMD's current stock price?

APMD (Apnimed, Inc.) is currently trading at $29.00 with a market cap of $1.15B.

What sector is Apnimed, Inc. in?

Apnimed, Inc. (APMD) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

APMD Apnimed, Inc.

NASDAQHealthcare

$29.00+3.17%ClosedMarket Cap: $1.15B

As of 2026-09-18

Why APMD matters now

Apnimed, Inc. (APMD) is a US stock in Healthcare. The latest InvestLog snapshot shows $29.00 with +3.17% on the session and $1.15B in market capitalization.

The latest indexable market news headline is "Apnimed: What We Know Heading Into The Feb PDUFA" from Seeking Alpha.

Latest News

Apnimed: What We Know Heading Into The Feb PDUFASeeking Alpha · 2026-09-10

Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate UpdateGlobeNewsWire · 2026-09-08

Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire · 2026-09-04

Apnimed, Inc.’s Quiet Period Will End on September 9th (NASDAQ:APMD)Defense World · 2026-09-02

Apnimed shares surge on bullish BofA initiationProactive Investors · 2026-08-25

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

0.00

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.